Escherichia coli antibiotic resistance in emergency departments. Do local resistance rates matter?

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 34, Issue 3, 2015, Pages 571-577

  Grignon, O ^a   Montassier, E ^a,b   Corvec, S ^a,b   Lepelletier, D ^a,b   Hardouin, J B ^c   Caillon, J ^a,b   Batard, E ^a,b  

^a HÔTEL DIEU   (France)

^b UNIVERSITÉ DE NANTES   (France)

^c Universite de Nantes   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; CEFOTAXIME; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; TRIMETHOPRIM; ANTIINFECTIVE AGENT;

ADULT; AGE; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ANTIMICROBIAL THERAPY; ARTICLE; BACTERIUM ISOLATE; EMERGENCY WARD; ESCHERICHIA COLI; FEASIBILITY STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NONHUMAN; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SEX; URINALYSIS; URINARY TRACT INFECTION; VERY ELDERLY; YOUNG ADULT; ADOLESCENT; DRUG EFFECTS; EMERGENCY HEALTH SERVICE; ESCHERICHIA COLI INFECTIONS; FRANCE; ISOLATION AND PURIFICATION; MICROBIOLOGY; PREVALENCE; URINE;

ADOLESCENT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CIPROFLOXACIN; DRUG RESISTANCE, BACTERIAL; EMERGENCY SERVICE, HOSPITAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; FRANCE; HUMANS; MALE; MIDDLE AGED; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION; URINE; YOUNG ADULT;

EID: 84941733877     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-014-2264-y     Document Type: Article

References (19)

1. Caterino JM, Ting SA, Sisbarro SG et al (2012) Age, nursing home residence, and presentation of urinary tract infection in U.S. emergency departments, 2001–2008. Acad Emerg Med 19:1173–1180
2. Elkharrat D, Brun-Ney D, Cordier B et al (2003) Prescriptions d’antibiotiques dans 34 services d’accueil et de traitement des urgences français Antimicrobial drugs prescribing in 34 french emergency department. Med Mal Infect 33:70–77
3. Gupta K, Hooton TM, Naber KG et al (2011) International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis 52:e103–e120
4. Lemort ML, Neuville S, Medus M et al (2006) Comparative susceptibility evolution in Escherichia coli from urinary tract infections in outpatients and inpatients at Perpignan hospital in 2002 and 2004. Pathol Biol (Paris) 54:427–430
5. Moffett SE, Frazee BW, Stein JC et al (2012) Antimicrobial resistance in uncomplicated urinary tract infections in 3 California EDs. Am J Emerg Med 30:942–949
6. Khawcharoenporn T, Vasoo S, Ward E et al (2012) High rates of quinolone resistance among urinary tract infections in the ED. Am J Emerg Med 30:68–74
7. Filiatrault L, McKay RM, Patrick DM et al (2012) Antibiotic resistance in isolates recovered from women with community-acquired urinary tract infections presenting to a tertiary care emergency department. Can J Emerg Med 14:295–305
8. Talan DA, Krishnadasan A, Abrahamian FM et al (2008) Prevalence and risk factor analysis of trimethoprim-sulfamethoxazole- and fluoroquinolone-resistant Escherichia coli infection among emergency department patients with pyelonephritis. Clin Infect Dis 47:1150–1158
9. Sun L, Klein EY, Laxminarayan R (2012) Seasonality and temporal correlation between community antibiotic use and resistance in the United States. Clin Infect Dis 55:687–694
10. Mahamat A, Lavigne JP, Fabbro-Peray P et al (2005) Evolution of fluoroquinolone resistance among Escherichia coli urinary tract isolates from a French university hospital: application of the dynamic regression model. Clin Microbiol Infect 11:301–306
11. Vernaz N, Huttner B, Muscionico D et al (2011) Modelling the impact of antibiotic use on antibiotic-resistant Escherichia coli using population-based data from a large hospital and its surrounding community. J Antimicrob Chemother 66:928–935
12. Gallini A, Degris E, Desplas M et al (2010) Influence of fluoroquinolone consumption in inpatients and outpatients on ciprofloxacin-resistant Escherichia coli in a university hospital. J Antimicrob Chemother 65:2650–2657
13. Thibaut S, Caillon J, Huart C et al (2010) Susceptibility to the main antibiotics of Escherichia coli and Staphylococcus aureus strains identified in community acquired infections in France (MedQual, 2004–2007). Med Mal Infect 40:74–80
14. Aldeyab MA, Harbarth S, Vernaz N et al (2012) The impact of antibiotic use on the incidence and resistance pattern of extended-spectrum beta-lactamase-producing bacteria in primary and secondary healthcare settings. Br J Clin Pharmacol 74:171–179
15. Gottesman BS, Carmeli Y, Shitrit P et al (2009) Impact of quinolone restriction on resistance patterns of Escherichia coli isolated from urine by culture in a community setting. Clin Infect Dis 49:869–875
16. Willemsen I, Cooper B, van Buitenen C et al (2010) Improving quinolone use in hospitals by using a bundle of interventions in an interrupted time series analysis. Antimicrob Agents Chemother 54:3763–3769
17. Slekovec C, Leroy J, Huttner A et al (2014) When the precautionary principle disrupts 3 years of antibiotic stewardship: nitrofurantoin in the treatment of urinary tract infections. J Antimicrob Chemother 69:282–284
18. Batard E, Ollivier F, Boutoille D et al (2013) Relationship between hospital antibiotic use and quinolone resistance in Escherichia coli. Int J Infect Dis 17:e254–e258
19. Kiffer CR, Camargo EC, Shimakura SE et al (2011) A spatial approach for the epidemiology of antibiotic use and resistance in community-based studies: the emergence of urban clusters of Escherichia coli quinolone resistance in Sao Paulo, Brasil. Int J Health Geogr 10:17